On Monday, scPharmaceuticals Inc (NASDAQ: SCPH) opened higher 13.81% from the last session, before settling in for the closing price of $4.85. Price fluctuations for SCPH have ranged from $1.94 to $6.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -1.52% over the past five years. Company’s average yearly earnings per share was noted 42.15% at the time writing. With a float of $36.11 million, this company’s outstanding shares have now reached $53.29 million.
Let’s look at the performance matrix of the company that is accounted for 164 employees.
scPharmaceuticals Inc (SCPH) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of scPharmaceuticals Inc is 32.25%, while institutional ownership is 56.58%.
scPharmaceuticals Inc (SCPH) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.37 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.3) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.15% per share during the next fiscal year.
scPharmaceuticals Inc (NASDAQ: SCPH) Trading Performance Indicators
Check out the current performance indicators for scPharmaceuticals Inc (SCPH). In the past quarter, the stock posted a quick ratio of 3.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.16 in one year’s time.
Technical Analysis of scPharmaceuticals Inc (SCPH)
scPharmaceuticals Inc (NASDAQ: SCPH) saw its 5-day average volume 3.69 million, a positive change from its year-to-date volume of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 63.49%.
During the past 100 days, scPharmaceuticals Inc’s (SCPH) raw stochastic average was set at 82.49%, which indicates a significant decrease from 93.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was higher than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.62, while its 200-day Moving Average is $3.57. Nevertheless, the first resistance level for the watch stands at $5.60 in the near term. At $5.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.74. If the price goes on to break the first support level at $5.46, it is likely to go to the next support level at $5.40. The third support level lies at $5.32 if the price breaches the second support level.
scPharmaceuticals Inc (NASDAQ: SCPH) Key Stats
There are currently 53,298K shares outstanding in the company with a market cap of 294.22 million. Presently, the company’s annual sales total 36,330 K according to its annual income of -85,150 K. Last quarter, the company’s sales amounted to 16,040 K and its income totaled -18,020 K.
